DioGenix

DioGenix is engaged in the discovery, development, and commercialization of non-invasive diagnostic, prognostic, and therapeutic response monitoring tests. Its primary program aims to provide neurologists with a series of clinical trials to diagnose early MS, categorize MS patients into clinical subtypes, and predict treatment response using non-invasive blood tests. The company was founded in 2007 and is headquartered in Gaithersburg, Maryland. As of September 19, 2008, DioGenix operated as a subsidiary of Nerveda.